Skip to main content

Table 3 Factor affecting EQ-5D utility score and EQ-VAS score difference

From: The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study

Variable Utility Score Difference P EQ-VAS Score Difference P
Gender
 Male, n = 3 0.011 ± 0.018 0.083 11.67 ± 7.64 0.242
 Female, n = 15 0.001 ± 0.109 16.67 ± 5.77
Age
 < 38 y.o, n = 9 0.089 ± 0.114 0.656 4.44 ± 9.17 0.119
 ≥ 38 y.o, n = 9 0.122 ± 0.210 10 ± 7.50
Education status
 Low, n = 2 0.254 ± 0.530 1.000 15 ± 7.10 0.166
 High, n = 16 0.062 ± 0.042 6.25 ± 8.47
Marital Status
 Married, n = 15 0.052 ± 0.034 0.339 13.33 ± 11.55 0.460
 Not Married, n = 3 0.185 ± 0.160 5 ± 13.23
Occupation
 Employed, n = 5 0.027 ± 0.045 0.091 9 ± 7.42 0.443
 Unemployed, n = 13 0.494 ± 0.460 4 ± 8.9
Other treatment
 With treatment, n = 8 0.192 ± 0.208 0.089 5 ± 9.64 0.249
 No treatment, n = 10 0.051 ± 0.050 8.13 ± 8.43
Comorbid disease
 With comorbid disease, n = 2 0.099 ± 0.140 0.944 2.5 ± 3.54 0.511
 Without comorbid disease, n = 16 0.106 ± 0.171 10 ± 14.14
  1. Description: Mann Whitney test analysis results showed p value> 0.05 in all sub groups. This means that there is no statistically significant difference between the factors affecting HRQoL to the difference of EQ-5D utility score and EQ-VAS score, * p < 0.05